Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

LB Pharmaceuticals Inc Common Stock, Common Stock

LBRX

NMQ

$15.71

-$0.29

(-1.81%)

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$359.09M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

61.33K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$13.36 L

$20.25 H

$15.71

About LB Pharmaceuticals Inc Common Stock, Common Stock

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 1 clinical trial for the treatment of bipolar I depression; and in pr clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York. more

Returns

Data is not properly formatted.

Time Frame	LBRX		S&P500
1-Week Return	-4.9%%	%	0.93%%
1-Month Return	-1.94%%	%	0.38%%
3-Month Return	-9.19%%	%	6.77%%

Financials

	Dec '22	Dec '23	Dec '24
Total Revenue	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	2.81M	11.38M	64.83M	[{"date":"2022-12-31","value":4.33,"profit":true},{"date":"2023-12-31","value":17.55,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(2.81M)	(11.38M)	(64.83M)	[{"date":"2022-12-31","value":-280900000,"profit":false},{"date":"2023-12-31","value":-1137600000,"profit":false},{"date":"2024-12-31","value":-6483000000,"profit":false}]
Total Non-Operating Income/Expense	(11.54M)	5.10M	1.73M	[{"date":"2022-12-31","value":-226.15,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":33.89,"profit":true}]
Pre-Tax Income	(14.35M)	(6.27M)	(63.10M)	[{"date":"2022-12-31","value":-1434700000,"profit":false},{"date":"2023-12-31","value":-627400000,"profit":false},{"date":"2024-12-31","value":-6310100000,"profit":false}]
Income Taxes	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	(14.35M)	(6.28M)	(63.10M)	[{"date":"2022-12-31","value":-1434800000,"profit":false},{"date":"2023-12-31","value":-627500000,"profit":false},{"date":"2024-12-31","value":-6310200000,"profit":false}]
Income From Discontinued Operations	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(14.35M)	(6.28M)	(63.10M)	[{"date":"2022-12-31","value":-1434800000,"profit":false},{"date":"2023-12-31","value":-627500000,"profit":false},{"date":"2024-12-31","value":-6310200000,"profit":false}]

EPS (Diluted)	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

	Dec '22	Dec '23	Dec '24
Total Revenue	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	304.98%	469.88%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":64.91,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	-	304.98%	469.88%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":64.91,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	(144.22%)	(66.11%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Pre-Tax Income	-	(56.27%)	905.75%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-6.21,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(56.27%)	905.61%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-6.21,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	(56.27%)	905.61%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-6.21,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

	Mar '24	Jun '24
Total Revenue	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Operating Expenses	16.63M	26.58M	[{"date":"2024-03-31","value":62.56,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Operating Income	(16.63M)	(26.58M)	[{"date":"2024-03-31","value":-1662800000,"profit":false},{"date":"2024-06-30","value":-2658000000,"profit":false}]
Total Non-Operating Income/Expense	474.00K	(1.12M)	[{"date":"2024-03-31","value":100,"profit":true},{"date":"2024-06-30","value":-235.44,"profit":false}]
Pre-Tax Income	(16.15M)	(27.70M)	[{"date":"2024-03-31","value":-1615400000,"profit":false},{"date":"2024-06-30","value":-2769600000,"profit":false}]
Income Taxes	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Income From Continuous Operations	(16.15M)	(27.70M)	[{"date":"2024-03-31","value":-1615400000,"profit":false},{"date":"2024-06-30","value":-2769600000,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Net Income	(16.15M)	(27.70M)	[{"date":"2024-03-31","value":-1615400000,"profit":false},{"date":"2024-06-30","value":-2769600000,"profit":false}]

EPS (Diluted)	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

	Mar '24	Jun '24
Total Revenue	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Operating Expenses	-	59.85%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Operating Income	-	59.85%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	(335.44%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":null,"profit":false}]
Pre-Tax Income	-	71.45%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Income Taxes	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Income From Continuous Operations	-	71.45%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Income From Discontinued Operations	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Net Income	-	71.45%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]

EPS (Diluted)	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	21.49M	45.63M	28.88M	[{"date":"2022-12-31","value":47.09,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":63.28,"profit":true}]
Non-current Assets	3.00K	23.00K	4.66M	[{"date":"2022-12-31","value":0.06,"profit":true},{"date":"2023-12-31","value":0.49,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	21.49M	45.66M	33.53M	[{"date":"2022-12-31","value":47.07,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":73.45,"profit":true}]

Total Liabilities
Current Liabilities	469.00K	2.61M	8.11M	[{"date":"2022-12-31","value":5.78,"profit":true},{"date":"2023-12-31","value":32.14,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	49.84M	77.52M	119.98M	[{"date":"2022-12-31","value":41.54,"profit":true},{"date":"2023-12-31","value":64.61,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	50.30M	80.13M	128.09M	[{"date":"2022-12-31","value":39.27,"profit":true},{"date":"2023-12-31","value":62.56,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	(34.95M)	(41.22M)	(104.32M)	[{"date":"2022-12-31","value":-3494600000,"profit":false},{"date":"2023-12-31","value":-4122100000,"profit":false},{"date":"2024-12-31","value":-10432300000,"profit":false}]
Other Stockholders' Equity	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	(28.81M)	(34.47M)	(94.55M)	[{"date":"2022-12-31","value":-2881200000,"profit":false},{"date":"2023-12-31","value":-3447300000,"profit":false},{"date":"2024-12-31","value":-9455400000,"profit":false}]

Total Liabilities & Shareholders Equity	21.49M	45.66M	33.53M	[{"date":"2022-12-31","value":47.07,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":73.45,"profit":true}]

	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	-	112.36%	(36.72%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-32.68,"profit":false}]
Non-current Assets	-	666.67%	20139.13%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":3.31,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	-	112.44%	(26.55%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-23.62,"profit":false}]

Total Liabilities
Current Liabilities	-	455.65%	211.17%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":46.34,"profit":true}]
Non-current Liabilities	-	55.56%	54.76%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":98.56,"profit":true}]
Total Liabilities	-	59.29%	59.85%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":99.07,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	-	17.96%	153.08%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":11.73,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	19.65%	174.28%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":11.27,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	112.44%	(26.55%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-23.62,"profit":false}]

	Mar '24	Jun '25
Total Assets
Current Assets	74.19M	14.78M	[{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-06-30","value":19.92,"profit":true}]
Non-current Assets	67.00K	4.47M	[{"date":"2024-03-31","value":1.5,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Total Assets	74.26M	19.25M	[{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-06-30","value":25.92,"profit":true}]

Total Liabilities
Current Liabilities	8.68M	3.91M	[{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-06-30","value":44.99,"profit":true}]
Non-current Liabilities	116.02M	119.22M	[{"date":"2024-03-31","value":97.32,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Total Liabilities	124.71M	123.12M	[{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-06-30","value":98.73,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Retained Earnings	(57.38M)	(114.50M)	[{"date":"2024-03-31","value":-5737500000,"profit":false},{"date":"2025-06-30","value":-11450000000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Total Shareholders' equity	(50.45M)	(103.87M)	[{"date":"2024-03-31","value":-5044600000,"profit":false},{"date":"2025-06-30","value":-10387300000,"profit":false}]

Total Liabilities & Shareholders Equity	74.26M	19.25M	[{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-06-30","value":25.92,"profit":true}]

	Mar '24	Jun '25
Total Assets
Current Assets	-	(80.08%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-06-30","value":null,"profit":false}]
Non-current Assets	-	6567.16%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Total Assets	-	(74.08%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-06-30","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	(55.01%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-06-30","value":null,"profit":false}]
Non-current Liabilities	-	2.75%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Total Liabilities	-	(1.27%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-06-30","value":null,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Retained Earnings	-	99.56%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Total Shareholders' equity	-	105.91%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(74.08%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-06-30","value":null,"profit":false}]

	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	(2.73M)	(12.09M)	(53.05M)	[{"date":"2022-12-31","value":-272800000,"profit":false},{"date":"2023-12-31","value":-1209400000,"profit":false},{"date":"2024-12-31","value":-5305200000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	22.96M	33.68M	38.31M	[{"date":"2022-12-31","value":59.93,"profit":true},{"date":"2023-12-31","value":87.9,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	20.36M	(6.42M)	8.50M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-31.56,"profit":false},{"date":"2024-12-31","value":41.74,"profit":true}]

Free Cash Flow
Free Cash Flow	(2.73M)	(12.12M)	(53.82M)	[{"date":"2022-12-31","value":-272800000,"profit":false},{"date":"2023-12-31","value":-1211900000,"profit":false},{"date":"2024-12-31","value":-5382100000,"profit":false}]

	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	-	343.33%	338.66%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":98.64,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	46.67%	13.77%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":29.49,"profit":true}]

Net Change in Cash	-	(131.56%)	(232.25%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	344.24%	344.10%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":99.96,"profit":true}]

	Mar '24	Jun '24
Operating Activities
Net Operating Cash Flow	(9.57M)	(15.78M)	[{"date":"2024-03-31","value":-957300000,"profit":false},{"date":"2024-06-30","value":-1577700000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	38.29M	3.00K	[{"date":"2024-03-31","value":100,"profit":true},{"date":"2024-06-30","value":0.01,"profit":true}]

Net Change in Cash	2.65M	(8.89M)	[{"date":"2024-03-31","value":100,"profit":true},{"date":"2024-06-30","value":-334.76,"profit":false}]

Free Cash Flow
Free Cash Flow	(9.62M)	(15.82M)	[{"date":"2024-03-31","value":-962000000,"profit":false},{"date":"2024-06-30","value":-1581800000,"profit":false}]

	Mar '24	Jun '24
Operating Activities
Net Operating Cash Flow	-	64.81%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(99.99%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":null,"profit":false}]

Net Change in Cash	-	(434.76%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	64.43%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	LBRX
Current Ratio	3.78

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	LBRX
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	LBRX
Debt Ratio Lower is generally better. Negative is bad.	6.40
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-5.40

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	LBRX
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is LB Pharmaceuticals Inc Common Stock share price today?

LB Pharmaceuticals Inc Common Stock (LBRX) share price today is $15.71

Can Indians buy LB Pharmaceuticals Inc Common Stock shares?

Yes, Indians can buy shares of LB Pharmaceuticals Inc Common Stock (LBRX) on Vested. To buy LB Pharmaceuticals Inc Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LBRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of LB Pharmaceuticals Inc Common Stock be purchased?

Yes, you can purchase fractional shares of LB Pharmaceuticals Inc Common Stock (LBRX) via the Vested app. You can start investing in LB Pharmaceuticals Inc Common Stock (LBRX) with a minimum investment of $1.

How to invest in LB Pharmaceuticals Inc Common Stock shares from India?

You can invest in shares of LB Pharmaceuticals Inc Common Stock (LBRX) via Vested in three simple steps:

Click on Sign Up or Invest in LBRX stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in LB Pharmaceuticals Inc Common Stock shares

What is LB Pharmaceuticals Inc Common Stock 52-week high and low stock price?

The 52-week high price of LB Pharmaceuticals Inc Common Stock (LBRX) is $20.25. The 52-week low price of LB Pharmaceuticals Inc Common Stock (LBRX) is $13.36.

What is LB Pharmaceuticals Inc Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of LB Pharmaceuticals Inc Common Stock (LBRX) is 0.00

What is the Market Cap of LB Pharmaceuticals Inc Common Stock?

The market capitalization of LB Pharmaceuticals Inc Common Stock (LBRX) is $359.09M

What is LB Pharmaceuticals Inc Common Stock’s stock symbol?

The stock symbol (or ticker) of LB Pharmaceuticals Inc Common Stock is LBRX

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Mutual Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

LB Pharmaceuticals Inc Common Stock, Common Stock

LBRX

NMQ

$15.71

-$0.29

(-1.81%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About LB Pharmaceuticals Inc Common Stock, Common Stock

Returns

Financials

Ratios

Liquidity

Asset Efficiency

Liabilities

Valuation

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²